Conversations with Tyler cover image

Daniel Carpenter on Smart Regulation

Conversations with Tyler

00:00

FDA's Pandemic Response & Vaccine Approval Challenges

This chapter critiques the FDA's delayed response to COVID-19 testing and vaccine approvals, particularly focusing on the AstraZeneca vaccine. It highlights how regulatory caution impacted public trust and vaccination rates in the U.S. compared to more rapid approaches in other countries. The discussion further delves into ethical considerations around drug trials and the implications of public perception on vaccine hesitancy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app